KCNJ8 Protein

KCNJ8 Protein

Introduction

Kcnj8 Protein (Kir6.1/KATP Channel) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@pmidhttpspubmedncbinlmnihgov2016]
title: KCNJ8 Protein [@pmidhttpspubmedncbinlmnihgov2015]
description: Protein page for Kir6.1 / KATP Channel [@pmidhttpspubmedncbinlmnihgov2015a]

--- [@pmidhttpspubmedncbinlmnihgov2007]

<div class="infobox infobox-protein"> [@pmidhttpspubmedncbinlmnihgov2005]

| | | [@pmidhttpspubmedncbinlmnihgov2019]
|---|---|
| Protein Name | Kir6.1 / KATP Channel |
| Gene | [KCNJ8](/proteins/kcnj8-protein) |
| UniProt ID | [ Q15818 ](https://www.uniprot.org/uniprot/Q15818) |
| PDB ID | 6C6P |
| Molecular Weight | 48 kDa |
| Subcellular Localization | Plasma membrane (neurons, cardiac myocytes, smooth muscle) |
| Protein Family | Inward-rectifier potassium channel family (Kir6.x) |

</div>

Overview

Kir6.1 is the pore-forming subunit of ATP-sensitive potassium (KATP) channels that couple cellular metabolism to electrical excitability. These channels open during metabolic stress to protect cells from ischemic injury. In the brain, Kir6.1/SUR1 channels are important for neuroprotection during ischemia and may be therapeutic targets for stroke and neurodegenerative diseases [1][2].

Protein Structure and Domain Architecture

Kir6.1 is a member of the inward-rectifier potassium channel (Kir) family with unique features for ATP sensing:

KCNJ8 Protein

Introduction

Kcnj8 Protein (Kir6.1/KATP Channel) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@pmidhttpspubmedncbinlmnihgov2016]
title: KCNJ8 Protein [@pmidhttpspubmedncbinlmnihgov2015]
description: Protein page for Kir6.1 / KATP Channel [@pmidhttpspubmedncbinlmnihgov2015a]

--- [@pmidhttpspubmedncbinlmnihgov2007]

<div class="infobox infobox-protein"> [@pmidhttpspubmedncbinlmnihgov2005]

| | | [@pmidhttpspubmedncbinlmnihgov2019]
|---|---|
| Protein Name | Kir6.1 / KATP Channel |
| Gene | [KCNJ8](/proteins/kcnj8-protein) |
| UniProt ID | [ Q15818 ](https://www.uniprot.org/uniprot/Q15818) |
| PDB ID | 6C6P |
| Molecular Weight | 48 kDa |
| Subcellular Localization | Plasma membrane (neurons, cardiac myocytes, smooth muscle) |
| Protein Family | Inward-rectifier potassium channel family (Kir6.x) |

</div>

Overview

Kir6.1 is the pore-forming subunit of ATP-sensitive potassium (KATP) channels that couple cellular metabolism to electrical excitability. These channels open during metabolic stress to protect cells from ischemic injury. In the brain, Kir6.1/SUR1 channels are important for neuroprotection during ischemia and may be therapeutic targets for stroke and neurodegenerative diseases [1][2].

Protein Structure and Domain Architecture

Kir6.1 is a member of the inward-rectifier potassium channel (Kir) family with unique features for ATP sensing:

• Transmembrane Domains: Two transmembrane helices (M1 and M2) that form the channel pore
• Pore Region (H5/P-loop): Contains the K⁺ selectivity filter with the GYG motif
• N-terminus: Intracellular region involved in channel gating and ATP sensitivity
• C-terminus: Contains the ATP-binding domain and regulatory regions
• Walker A/B Motifs: Present in the C-terminus for nucleotide binding

Normal Function

Metabolic Coupling

Kir6.1-containing KATP channels function as metabolic sensors:

Tissue Distribution

• Brain: [Neurons](/entities/neurons) and glia express Kir6.1/SUR1 channels, particularly in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and basal ganglia
• Cardiovascular System: High expression in cardiac myocytes and vascular smooth muscle
• Pancreas: Kir6.2 (KCNJ11) predominates in insulin-secreting β-cells

Role in Disease

Alzheimer's Disease

Kir6.1 channels are implicated in Alzheimer's disease pathogenesis:

• Metabolic Dysfunction: AD brains exhibit impaired glucose metabolism and altered ATP sensing
• Amyloid-β Interaction: [Aβ](/proteins/amyloid-beta) peptides can modulate KATP channel activity
• Ischemic Preconditioning: Activation of Kir6.1 channels may protect against Aβ toxicity [3]
• Therapeutic Potential: KATP channel openers may improve neuronal survival

Parkinson's Disease

Kir6.1 channels modulate dopaminergic neuron survival:

• Metabolic Stress Response: Dopaminergic neurons are particularly vulnerable to metabolic impairment
• Mitochondrial Dysfunction: PINK1/Parkin pathway interacts with KATP channel regulation
• Neuroprotection: Kir6.1 activation may protect substantia nigra neurons [4]

Stroke and Ischemia

KATP channels are critical for ischemic neuroprotection:

• Ischemic Preconditioning: Brief ischemia activates KATP channels, protecting against subsequent severe ischemia
• Neuronal Survival: Kir6.1/SUR1 activation reduces infarct size in experimental stroke models
• [Blood-Brain Barrier](/entities/blood-brain-barrier): KATP modulation affects BBB permeability during ischemia [5]

Cantu Syndrome

Gain-of-function KCNJ8 mutations cause Cantu syndrome:

• Cardiovascular Features: Vasodilation, hypotension, and cardiac hypertrophy
• Neurological Features: Some patients exhibit neurodevelopmental delays
• Mechanism: Mutations reduce ATP sensitivity, causing constitutive channel opening

Therapeutic Targeting

Modulating Kir6.1/KATP channel function represents therapeutic strategies:

Current Approaches

• KATP Channel Openers: Pinacidil, cromakalim for neuroprotection research
• Sulfonylureas: Glibenclamide blocks SUR1; used in stroke clinical trials
• Metabolic Modulators: Compounds that target cellular energetics

Clinical Trials

• Phase II: SUR1 blockers (glibenclamide) for traumatic brain injury
• Preclinical: KATP openers for ischemic stroke and AD

Pathway Interactions

Kir6.1 participates in key metabolic and signaling pathways:

• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction) - Energy metabolism
• [Excitotoxicity Pathway](/mechanisms/excitotoxicity) - Calcium homeostasis
• [Ischemic Injury Pathway](/mechanisms/ischemic-injury) - Stroke pathophysiology
• [Metabolic Stress Response](/mechanisms/metabolic-stress-response)

Interacting Proteins

• [ABCC8 (SUR1](/proteins/abcc8)) - Sulfonylurea receptor 1, regulatory subunit
• [KCNJ11 (Kir6.2](/proteins/kcnj11-protein)) - Alternative pore-forming subunit
• [SUR2 (ABCC9](/proteins/abcc9)) - Sulfonylurea receptor 2
• [Hexokinase](/proteins/hexokinase) - Metabolic enzyme that produces ATP

Background

The study of Kcnj8 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
• [Ion Channelopathies](/mechanisms/ion-channel-dysfunction)
• [Potassium Channels](/mechanisms/potassium-channel-dysfunction)
• Metabolic Dysfunction
• Ischemic Injury
• [Neuroprotection](/mechanisms/neuroprotection)

External Links

• [UniProt Q15818](https://www.uniprot.org/uniprot/Q15818)
• [PDB 6C6P](https://www.rcsb.org/structure/6C6P)
• [GeneCards KCNJ8](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNJ8)
• [IUPHAR Database](https://www.guidetopharmacology.org/target/379)

References

PMID: 23479634(https://pubmed.ncbi.nlm.nih.gov/23479634/) PMID: 25840056(https://pubmed.ncbi.nlm.nih.gov/25840056/) PMID: 25975241(https://pubmed.ncbi.nlm.nih.gov/25975241/) PMID: 20431955(https://pubmed.ncbi.nlm.nih.gov/20431955/) PMID: 16737952(https://pubmed.ncbi.nlm.nih.gov/16737952/) PMID: 28554347(https://pubmed.ncbi.nlm.nih.gov/28554347/)